CoChat

A retrospective study on weaning glucocorticoids and recovery of the hypothalamic-pituitary-adrenal axis

Open access
Arshad, Muhammad Fahad, Elder, Charlotte, Newell-Price, John, Ross, Richard, Debono, Miguel · 2024 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.

Abstract

CONTEXT: Glucocorticoids suppress the hypothalamic-pituitary-adrenal (HPA) axis, resulting in tertiary adrenal insufficiency (AI). When weaning patients off glucocorticoids there is no consensus on whether to maintain patients on prednisolone or convert to hydrocortisone. OBJECTIVE: To investigate HPA axis recovery in patients on long-term prednisolone and assess outcome after hydrocortisone conversion. METHODS: This was a retrospective cohort study at an outpatient endocrine steroid clinic. Patients were on long-term prednisolone and referred for HPA axis testing between 2015 and 2022. The main outcomes measured were (1) HPA axis recovery rate in patients on prednisolone demonstrated by a normal adrenocorticotrophic hormone (ACTH) stimulation test (AST) and (2) HPA axis recovery rate subanalysis of dose-matched patients with confirmed tertiary AI on prednisolone or hydrocortisone were measured. RESULTS: In total, 206 patients on prednisolone were tested for tertiary AI. Of these, 176 remained on prednisolone while 30 were converted to hydrocortisone. The overall HPA axis recovery rate for patients on prednisolone after interval testing was 137/206 (66.5%). The HPA axis recovery rate in dose-matched prednisolone and hydrocortisone conversion groups was 7/10 (70%) and 2/13 (15%) (P = .008), respectively. There was no difference in mean (SD) age (67.1 [12.2] vs 63.4 [11.1] years; P = .464) and baseline cortisol (5.3 [4.2] vs 4.6 [3.1] µg/dL; P = .648) and median [interquartile, IQR] glucocorticoid duration (1213 [1114] vs 2316 [4808] days; P = .693) and baseline ACTH (20.5 [29.0] vs 16.3 [14.8] ng/L; P = .905) between dose-matched prednisolone and hydrocortisone groups. Follow-up duration in the prednisolone group was significantly lower (median [IQR] 348 [975] vs 667 [884] days; P = .012). CONCLUSION: Patients with glucocorticoid-induced AI maintained on once-daily prednisolone can recover HPA axis function when weaning. There is no apparent advantage to recover HPA axis function in converting to multiple-dosing hydrocortisone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgae059

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Consort diagram outlining study methodology and primary outcome (created with biorender.com). Abbreviations: ACTH, adrenocorticotrophic hormone; AI, adrenal Insufficiency; AST, ACTH stimulation test. Patients on prednisolone ± inhaled glucocorticoids (n = 206) were included in the study. Of these, 30 were converted to hydrocortisone due to symptoms, while the remaining 176 were still taking prednisolone as their oral glucocorticoid. The patients on prednisolone underwent testing with serial ASTs until they passed the AST. Thirty-six patients were still either waiting further ASTs at the end of the study or were lost to follow-up or died. The overall weaning rate for patients on prednisolone only throughout the study period was 137/206 (66.5%).
Figure 1. Consort diagram outlining study methodology and primary outcome (created with biorender.com). Abbreviations: ACTH, adrenocorticotrophic hormone; AI, adrenal Insufficiency; AST, ACTH stimulation test. Patients on prednisolone ± inhaled glucocorticoids (n = 206) were included in the study. Of these, 30 were converted to hydrocortisone due to symptoms, while the remaining 176 were still taking prednisolone as their oral glucocorticoid. The patients on prednisolone underwent testing with serial ASTs until they passed the AST. Thirty-six patients were still either waiting further ASTs at the end of the study or were lost to follow-up or died. The overall weaning rate for patients on prednisolone only throughout the study period was 137/206 (66.5%).CC BY-NC-ND · PubMed Central
Figure 2. Consort diagram outlining study methodology and secondary outcome (created with biorender.com). Abbreviations: ACTH, adrenocorticotrophic hormone; AI, adrenal Insufficiency; AST, ACTH stimulation test. Of all patients referred to the steroid clinic who underwent AST testing, 161 failed the AST and had confirmed tertiary AI. Of these, only patients who were on prednisolone only and who underwent further AST testing (n = 71) were included in this analysis. Of these, 30 were converted to hydrocortisone due to symptoms while the rest (n = 41) remained on prednisolone. The patients in both groups were dose matched and recovery rates compared.
Figure 2. Consort diagram outlining study methodology and secondary outcome (created with biorender.com). Abbreviations: ACTH, adrenocorticotrophic hormone; AI, adrenal Insufficiency; AST, ACTH stimulation test. Of all patients referred to the steroid clinic who underwent AST testing, 161 failed the AST and had confirmed tertiary AI. Of these, only patients who were on prednisolone only and who underwent further AST testing (n = 71) were included in this analysis. Of these, 30 were converted to hydrocortisone due to symptoms while the rest (n = 41) remained on prednisolone. The patients in both groups were dose matched and recovery rates compared.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 1

  1. Arshad MF, Elder C, Newell-Price J, Ross R, Debono M. Supplementary data for main manuscript: A retrospective study on weaning glucocorticoids and recovery of the hypothalamic-pituitary-adrenal axis. The University of Sheffield. Online Research Data (figshare), 2024. 10.15131/shef.data.25103597.v1 PMC11479689 38298131 · DOI

Cited by

See all 12

Metadata

Authors
Arshad, M. F., Elder, C., Newell-Price, J., Ross, R., & Debono, M.
Affiliations
  • Sheffield Teaching Hospitals NHS Foundation Trust (GB)
  • Sheffield Children's NHS Foundation Trust (GB)
  • University of Sheffield (GB)
Corresponding author
Debono, Miguel
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2024-01-31
Volume
109
Issue
11
Pages
e2031-e2037
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4391447007
Cited by
12
References
39
Citations by year
2026: 3 · 2025: 6 · 2024: 3
FWCI
3.93
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
Funders
  • National Institute for Health and Care Research (CL-2015-04-002)
  • Academy of Medical Sciences (SGL015\1007)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
tertiary adrenal insufficiency, prednisolone, ACTH stimulation test, long-term corticosteroid therapy, adrenal function testing, steroid replacement therapy, glucocorticoid-induced adrenal suppression
MeSH terms
Adrenal Insufficiency, Adrenocorticotropic Hormone, Adult, Aged, Female, Glucocorticoids, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary-Adrenal System, Prednisolone, Retrospective Studies, Recovery of Function

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A retrospective study on weaning glucocorticoids and recovery of the hypothalamic-pituitary-adrenal axis. https://app.cochat.ai/papers/10.1210/clinem/dgae059
The paper
Arshad, M. F., Elder, C., Newell-Price, J., Ross, R., & Debono, M. (2024). A retrospective study on weaning glucocorticoids and recovery of the hypothalamic-pituitary-adrenal axis. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae059

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.